BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery

Solutions address shift from animal-based to more human-relevant organoid models, resulting in more accurate predictions in drug discovery Synergies wit...

April 10, 2024 | News

BioCity Biopharma's Cancer Therapy BC2027 Gets FDA Nod for Phase 1 Trials

BioCity Biopharma announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a Pha...

April 10, 2024 | News

Celonic and Revvity Forge Strategic Alliance to Accelerate Monoclonal Antibodies and Complex Protein Development

Celonic has signed a commercial license agreement with Revvity for its CHOSOURCE™ expression platform and TnT transposon technology. The R...

April 09, 2024 | News

YolTech Therapeutics Initiates Clinical Trial for Gene Editing Treatment YOLT-101 Targeting Familial Hypercholesterolemia

YolTech Therapeutics announced that the first patient has been dosed with YOLT-101, the company's in vivo genome editing candidate being develope...

April 03, 2024 | News

Bespak Completes Separation from Recipharm,Shifts Focus to Low GWP Inhalers

Bespak announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Gr...

April 02, 2024 | News

ISPRI Breakthrough Enhances Biologic Therapeutics Development

In the pursuit of developing novel biologic entities, scientists harnessing the power of AI and generative biology depend on computational to...

April 02, 2024 | News

Bridge Biotherapeutics Partners with Emory University to Combat Lung Cancer Resistance

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, ...

March 29, 2024 | News

Sanyou Bio: Pioneering the Future of Biologics R&D with Intelligence-Enabled Platform

Sanyou Biopharmaceuticals emerges as a frontrunner in the biotechnology sector. Under the vision of its founder and CEO, Dr. Guojun Lang, Sanyou Bi...

March 28, 2024 | Product Spotlight

EditCo Bio Launches with Acquisition of Synthego's Cell Engineering Divisions to Boost CRISPR Market Innovations

EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego's engineered cell solutions and enhanced guide RNA business. ...

March 28, 2024 | News

Integrated DNA Technologies Launches Innovative Custom Vector Onboarding Tool to Streamline Gene Synthesis

Integrated DNA Technologies (IDT), a global leader in genomics solutions, announced the expansion of its gene synthesis services with the launch of a...

March 28, 2024 | News

Altamira Therapeutics Partners with Univercells to Enhance mRNA Vaccine Delivery

Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company providing nanoparticle-based technology for...

March 26, 2024 | News

Alphamab Oncology Launches Groundbreaking Clinical Trial in Australia for Advanced Cancer Treatment

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been dosed in Australia in the clinical study (JSKN033-101) of JSKN0...

March 26, 2024 | News

Sino Biological Announces Services Partnership with Rapid Novor

This collaboration marks a significant stride in biotechnological services, covering major geographical regions including China, Singapore, Thailan...

March 22, 2024 | News

European Commission Approves Bristol Myers Squibb’s Abecma as First Earlier-Line CAR T Therapy for Multiple Myeloma"

Bristol Myers Squibb announced a significant advancement in the treatment of multiple myeloma with the European Commission's approval of Abecma® (ideca...

March 21, 2024 | News

Stay Connected